|

The nature of
Clinical Research makes budgeting and
tracking of study costs extremely
challenging. As studies are
delayed or priorities shift, the annual
research budget remains fixed. Find out how
3C Company has emerged as the leading
force in providing major pharma with systems
and solutions to plan, forecast, track and
manage clinical trial costs.
|
|
|
 |
Business Processes
3C Company
was engaged by the Research Finance department of
a large pharmaceutical company in late 1997 to
conduct a Business Process Re-engineering study of
its Clinical payment processes. This effort
identified several opportunities for improvements
through automation, kindling the flames for what
today are the Pillar, PIMS and Grants Management
System projects among others. The study took
roughly 4 months to complete, and did not exceed
its original budget of $30,000. |
|
|
 |
Budgetting & Forecasting
Information is currently unavailable for this
topic. |
|
|
 |
Contracts
Information is currently unavailable for this
topic. |
|
|
 |
Payments
The IPMS system was
originally developed by 3C as a software package,
with its first client the France subsidiary of
a large
pharmaceutical company. This office
needed to replace an older version of CTMS by DLB,
due to Y2K issues. Written in Visual Basic and
using Oracle as the database, an emphasis was
placed on integrating with PROSIT without
impacting it in any way. The new application was
implemented on time and for the originally
promised amount, with functionality exceeding the
original design and prototype. Some 30 users now
manage their clinical trial costs with this
system, and 3C Company adds another successful
project to its repertoire. |
|
|
 |
Cost Reduction
Information is currently unavailable for this
topic. |
|
|
|